MAFF inhibits angiogenesis in non-small cell lung cancer by suppressing YAP1 nuclear translocation
MAFF suppresses angiogenesis in NSCLC by blocking YAP1 nuclear translocation and downregulating VEGF and CTGF, highlighting its potential as a therapeutic target.
Authors
- Wannian Yang (ORCID: https://orcid.org/0000-0002-1246-7260)
- Weihang Ji
- Na Xiao (ORCID: https://orcid.org/0000-0003-2376-4073)
- Yao Ding (ORCID: https://orcid.org/0000-0003-2040-2640)
- Xiao Li (ORCID: https://orcid.org/0000-0001-7866-3160)
- Lin Liu (ORCID: https://orcid.org/0000-0001-7073-610X)
- Rui Hu (ORCID: https://orcid.org/0000-0002-1385-9047)
- Shizhi Wang (ORCID: https://orcid.org/0000-0002-6083-6753)
- Yuting Zou (ORCID: https://orcid.org/0000-0003-0720-6645)
- Z. Alexander Cao (ORCID: https://orcid.org/0000-0003-1790-9168)
- Yi Zeng (ORCID: https://orcid.org/0000-0002-6912-1009)
Institutions
- Jiangsu Food and Pharmaceutical Science College (CN)
- Affiliated Hospital of Youjiang Medical University for Nationalities (CN)
- Baise University (CN)
Publication Details
- Journal
- PeerJ
- Published
- 2025-11-20
- DOI
- https://doi.org/10.7717/peerj.20395
- Primary Topic
- Hippo pathway signaling and YAP/TAZ
- Type
- article
- Field-Weighted Citation Impact
- 0.00